These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38287814)

  • 1. O-glycoprofiling of Serum Apolipoprotein C-III in Colorectal Cancer.
    Kianičková K; Pakanová Z; Květoň F; Holazová A; Kundalia PH; Baráth P; Miljuš G; Nedić O; Katrlík J
    Front Biosci (Landmark Ed); 2024 Jan; 29(1):32. PubMed ID: 38287814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MALDI-TOF MS applied to apoC-III glycoforms of patients with congenital disorders affecting O-glycosylation. Comparison with two-dimensional electrophoresis.
    Yen-Nicolaÿ S; Boursier C; Rio M; Lefeber DJ; Pilon A; Seta N; Bruneel A
    Proteomics Clin Appl; 2015 Aug; 9(7-8):787-93. PubMed ID: 25641685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MALDI-MS profiling of serum O-glycosylation and N-glycosylation in COG5-CDG.
    Palmigiano A; Bua RO; Barone R; Rymen D; Régal L; Deconinck N; Dionisi-Vici C; Fung CW; Garozzo D; Jaeken J; Sturiale L
    J Mass Spectrom; 2017 Jun; 52(6):372-377. PubMed ID: 28444691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A capillary zone electrophoresis method for detection of Apolipoprotein C-III glycoforms and other related artifactually modified species.
    Ruel C; Morani M; Bruneel A; Junot C; Taverna M; Fenaille F; Tran NT
    J Chromatogr A; 2018 Jan; 1532():238-245. PubMed ID: 29221866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein C-III O-glycoform profiling of 500 serum samples by matrix-assisted laser desorption/ionization mass spectrometry for diagnosis of congenital disorders of glycosylation.
    Wada Y; Okamoto N
    J Mass Spectrom; 2021 Apr; 56(4):e4597. PubMed ID: 32677746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of IgG N-glycome profile in colorectal cancer progression by MALDI-TOF-MS.
    Liu S; Cheng L; Fu Y; Liu BF; Liu X
    J Proteomics; 2018 Jun; 181():225-237. PubMed ID: 29698801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays.
    Ueda K; Fukase Y; Katagiri T; Ishikawa N; Irie S; Sato TA; Ito H; Nakayama H; Miyagi Y; Tsuchiya E; Kohno N; Shiwa M; Nakamura Y; Daigo Y
    Proteomics; 2009 Apr; 9(8):2182-92. PubMed ID: 19322776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis.
    Wopereis S; Grünewald S; Morava E; Penzien JM; Briones P; García-Silva MT; Demacker PN; Huijben KM; Wevers RA
    Clin Chem; 2003 Nov; 49(11):1839-45. PubMed ID: 14578315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.
    Franc V; Řehulka P; Raus M; Stulík J; Novak J; Renfrow MB; Šebela M
    J Proteomics; 2013 Oct; 92():299-312. PubMed ID: 23891555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays.
    Cohen M; Yossef R; Erez T; Kugel A; Welt M; Karpasas MM; Bones J; Rudd PM; Taieb J; Boissin H; Harats D; Noy K; Tekoah Y; Lichtenstein RG; Rubin E; Porgador A
    PLoS One; 2011 Jan; 6(1):e14540. PubMed ID: 21267442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation.
    Balog CI; Stavenhagen K; Fung WL; Koeleman CA; McDonnell LA; Verhoeven A; Mesker WE; Tollenaar RA; Deelder AM; Wuhrer M
    Mol Cell Proteomics; 2012 Sep; 11(9):571-85. PubMed ID: 22573871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.
    Holst S; Deuss AJ; van Pelt GW; van Vliet SJ; Garcia-Vallejo JJ; Koeleman CA; Deelder AM; Mesker WE; Tollenaar RA; Rombouts Y; Wuhrer M
    Mol Cell Proteomics; 2016 Jan; 15(1):124-40. PubMed ID: 26537799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transferrin and apolipoprotein C-III isofocusing are complementary in the diagnosis of N- and O-glycan biosynthesis defects.
    Wopereis S; Grünewald S; Huijben KM; Morava E; Mollicone R; van Engelen BG; Lefeber DJ; Wevers RA
    Clin Chem; 2007 Feb; 53(2):180-7. PubMed ID: 17170056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying N-Glycan Biomarkers in Colorectal Cancer by Mass Spectrometry.
    Sethi MK; Hancock WS; Fanayan S
    Acc Chem Res; 2016 Oct; 49(10):2099-2106. PubMed ID: 27653471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoelectric Focusing of Serum Apolipoprotein C-III as a Sensitive Screening Method for the Detection of O-glycosylation Disturbances.
    Ondrušková N; Honzík T; Kytnarová J; Matoulek M; Zeman J; Hansíková H
    Prague Med Rep; 2015; 116(2):73-86. PubMed ID: 26093664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-Depth Analysis of the
    Wang D; Kuzyk V; Madunić K; Zhang T; Mayboroda OA; Wuhrer M; Lageveen-Kammeijer GSM
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal glycosylation with hypersialylated O-glycans in patients with Sialuria.
    Wopereis S; Abd Hamid UM; Critchley A; Royle L; Dwek RA; Morava E; Leroy JG; Wilcken B; Lagerwerf AJ; Huijben KM; Lefeber DJ; Rudd PM; Wevers RA
    Biochim Biophys Acta; 2006 Jun; 1762(6):598-607. PubMed ID: 16769205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) Receptors.
    Kegulian NC; Ramms B; Horton S; Trenchevska O; Nedelkov D; Graham MJ; Lee RG; Esko JD; Yassine HN; Gordts PLSM
    Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):2145-2156. PubMed ID: 31390883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Apolipoproteins Predicting the Occurrence and Severity of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus.
    Zhang X; Nie Y; Gong Z; Zhu M; Qiu B; Wang Q
    Front Endocrinol (Lausanne); 2022; 13():915575. PubMed ID: 35937834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of new apolipoprotein-CIII glycoforms with ultrahigh resolution MALDI-FTICR mass spectrometry of human sera.
    Nicolardi S; van der Burgt YE; Dragan I; Hensbergen PJ; Deelder AM
    J Proteome Res; 2013 May; 12(5):2260-8. PubMed ID: 23527852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.